Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jan 17 04:00PM ET
8.40
Dollar change
-0.13
Percentage change
-1.52
%
IndexRUT P/E- EPS (ttm)-2.26 Insider Own4.49% Shs Outstand160.15M Perf Week-9.82%
Market Cap1.35B Forward P/E67.20 EPS next Y0.12 Insider Trans-0.20% Shs Float152.99M Perf Month-8.99%
Income-284.86M PEG- EPS next Q-0.66 Inst Own59.01% Short Float24.13% Perf Quarter-17.24%
Sales885.19M P/S1.52 EPS this Y76.43% Inst Trans14.36% Short Ratio7.66 Perf Half Y-43.85%
Book/sh-3.29 P/B- EPS next Y109.80% ROA-16.91% Short Interest36.92M Perf Year99.76%
Cash/sh5.74 P/C1.46 EPS next 5Y- ROE- 52W Range3.53 - 23.86 Perf YTD4.48%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-64.79% Beta2.13
Dividend TTM- Quick Ratio0.93 Sales past 5Y653.01% Gross Margin66.95% 52W Low137.80% ATR (14)0.62
Dividend Ex-DateDec 13, 2007 Current Ratio0.93 EPS Y/Y TTM65.76% Oper. Margin-32.76% RSI (14)44.83 Volatility5.08% 6.41%
Employees1543 Debt/Eq- Sales Y/Y TTM-15.68% Profit Margin-32.18% Recom2.33 Target Price16.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q40.06% Payout- Rel Volume0.62 Prev Close8.53
Sales Surprise14.54% EPS Surprise3.93% Sales Q/Q-54.80% EarningsNov 12 BMO Avg Volume4.82M Price8.40
SMA20-4.21% SMA50-3.05% SMA200-22.49% Trades Volume2,969,668 Change-1.52%
Date Action Analyst Rating Change Price Target Change
Jul-30-24Downgrade JP Morgan Neutral → Underweight $8
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
Jan-17-25 01:55PM
Jan-15-25 05:45PM
Jan-08-25 04:03PM
09:13AM
09:13AM
09:00AM Loading…
09:00AM
06:09AM
Jan-07-25 04:12PM
11:26AM
Dec-24-24 09:00AM
Dec-13-24 09:59AM
08:00AM
Dec-12-24 11:30AM
04:34AM
Dec-10-24 09:00AM
08:00AM Loading…
08:00AM
Dec-09-24 08:08PM
Dec-05-24 05:30AM
Dec-04-24 06:07AM
03:03AM
02:00AM
Nov-29-24 09:00AM
Nov-21-24 03:35PM
Nov-18-24 09:00AM
Nov-15-24 04:19PM
12:04PM
12:04PM
10:46AM
07:47AM
05:21AM
02:08AM Loading…
02:08AM
Nov-14-24 04:28PM
Nov-13-24 08:00AM
02:08AM
Nov-12-24 02:43PM
02:43PM
12:52PM
10:33AM
09:48AM
09:44AM
09:20AM
08:13AM
08:05AM
08:02AM
Nov-11-24 12:49PM
09:07AM
08:58AM
08:30AM
06:53AM
Nov-08-24 01:02PM
Nov-06-24 01:13PM
Nov-05-24 10:00AM
Nov-04-24 04:30PM
06:00AM
Nov-01-24 09:00AM
Oct-29-24 05:45PM
Oct-26-24 12:29PM
12:29PM
Oct-23-24 05:45PM
Oct-22-24 04:00AM
Oct-21-24 09:00AM
07:45AM
Oct-19-24 06:15PM
Oct-17-24 05:45PM
10:07AM
08:18AM
07:08AM
Oct-16-24 04:34PM
03:50PM
01:20PM
11:58AM
10:56AM
10:30AM
10:07AM
09:45AM
09:16AM
08:14AM
Oct-14-24 05:19AM
Oct-11-24 01:36PM
Oct-10-24 05:45PM
Oct-09-24 05:33PM
07:00AM
Oct-08-24 09:00AM
Oct-07-24 05:49AM
Oct-06-24 01:41PM
Oct-03-24 05:45PM
03:27AM
Sep-26-24 11:39AM
Sep-25-24 09:00AM
08:00AM
Sep-23-24 05:45PM
01:15PM
Sep-17-24 05:07PM
Sep-16-24 07:52AM
Sep-13-24 01:09PM
09:25AM
07:50AM
Sep-11-24 09:00AM
Sep-05-24 10:00AM
Sep-04-24 09:25AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kelly James PatrickEVP, CFO and TreasurerDec 31 '24Option Exercise0.0035,000049,508Jan 03 05:41 PM
Rodgers Richard JDirectorOct 29 '24Option Exercise0.003,800014,270Jan 02 04:52 PM
King Rachel K.DirectorDec 13 '24Sale9.024,15037,43514,770Jan 02 04:47 PM
YOUNG JAMES FDirectorDec 31 '24Sale8.005,40043,20051,760Jan 02 04:44 PM
YOUNG JAMES FDirectorDec 24 '24Sale8.484,60039,00857,160Jan 02 04:44 PM
YOUNG JAMES FDirectorDec 24 '24Proposed Sale8.4810,00084,800Dec 26 10:31 AM
Casey Mark JEVP, Chief Legal OfficerDec 11 '24Option Exercise0.0041,900041,900Dec 13 05:24 PM
Rachel K. KingBoard MemberDec 13 '24Proposed Sale9.004,15037,350Dec 13 12:13 PM
Dubovsky FilipOfficerSep 18 '24Proposed Sale13.007,33595,331Sep 18 04:08 PM
Trizzino JohnEVP, CCO and CBOAug 19 '24Option Exercise0.00655028,627Aug 21 04:47 PM
Kelly James PatrickEVP, CFO and TreasurerAug 16 '24Option Exercise12.962,36730,67615,652Aug 20 05:06 PM
YOUNG JAMES FDirectorJun 21 '24Sale14.097,500105,67561,760Jun 25 04:12 PM
YOUNG JAMES FDirectorJun 18 '24Sale13.727,500102,88169,260Jun 21 04:21 PM
Dubovsky FilipPresident, R&DJun 17 '24Option Exercise6.1813,90485,91180,517Jun 20 05:08 PM
Dubovsky FilipPresident, R&DJun 17 '24Sale14.4713,904201,16466,613Jun 20 05:08 PM
MCGLYNN MARGARET GDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:14 PM
Alton Gregg HDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:11 PM
DOUGLAS RICHARDDirectorJun 12 '24Option Exercise0.006,670043,920Jun 14 04:10 PM
King Rachel K.DirectorJun 12 '24Option Exercise0.006,670018,920Jun 14 04:07 PM
MOTT DAVID MDirectorJun 12 '24Option Exercise0.006,670050,470Jun 14 04:06 PM
Rodgers Richard JDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:05 PM
YOUNG JAMES FDirectorJun 12 '24Option Exercise0.006,670076,760Jun 14 04:01 PM
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM